Skip to content

Bio-Perspectives

Active Private limited companyfounded 2023active for 3 yearsKroonlaan 378, 1050 IxellesKBO/BCE: BE 1000.325.168

Lifetime

2 annual accounts with figures on one time axis
peak of €136,555 in 2024
€104,857▼ 23.2%
peak of €106,993 in 2024
€79,613▼ 25.6%
peak of €168,178 in 2025
€168,178▲ 52.9%
€38,582▲ 135%
Board1 name since 2023
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Gross margin from €136,555 to €104,857Result from €106,993 to €79,613Dividend €21,429Equity from €109,993 to €168,178Debts from €16,387 to €38,582Cash from €53,247 to €145,067

Key points

from the 2025 annual accounts

Equity

€168,178 ▲ 52.9%
€110,0002024€168,0002025

Equity rose in 2025 from €109,993 to €168,178.

Turnover

≈ €260,000 estimated

The micro format states no turnover.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as Bio-Perspectives has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for Bio-Perspectives. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 28-09-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1000325168
First establishment Kroonlaan 378, Ixelles
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 28-09-2023 · Gazette deed
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Bio-Perspectives Ixelles €206,760 €104,857 81.3% -
TereLabs Brussels €207,737 €83,807 78.1% -
Ceperitus Ghent €217,514 €84,912 51.5% -
DEDAL Ixelles €139,276 €73,605 70.7% -
Epitech Research Auderghem €132,574 €59,658 87.0% -
PLT ANALYSIS Waterloo €305,968 €140,126 68.4% -
EDF Quality Services Zoersel €313,863 €87,372 69.2% -

These companies have the same main activity as Bio-Perspectives: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €133,000 and €314,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 26-09-2023Normal situation
Registered office
11 active companies are registered at this addressSource: KBO register, as of 22 November 2026.
Activity
Research and development on biotechnologyNACE 72101and 5 others
Establishment unit
2.351.124.1071050 Ixelles, since 01-10-2023
Financial year end
31 December
Peppol
Reachable since 03-10-2023
Company details

Annual accounts 2025

€206,760▲ 63.6%
Filing
Filed on 24-06-2026, 37 days before the end of the filing period
Financials

Insights on Bio-Perspectives

Bio-Perspectives has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €168,178 and a net result of €79,613.

Its solvency ranks better than 71% of 668 sector peers (NACE 72) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Bio-Perspectives

What is the company number of Bio-Perspectives?
The company number of Bio-Perspectives is 1000.325.168. The VAT number is the same number with BE in front: BE 1000.325.168.
Where is Bio-Perspectives based?
The registered office is at Kroonlaan 378, 1050 Ixelles.Company details
What does Bio-Perspectives do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Bio-Perspectives?
Bio-Perspectives is a private limited company (BV).
When was Bio-Perspectives founded?
Bio-Perspectives was founded on 26-09-2023.
Is Bio-Perspectives still active?
Yes, Bio-Perspectives is an active enterprise in the KBO register.
What is the turnover of Bio-Perspectives?
The turnover in financial year 2025 is about €260,000. This figure is estimated from the gross margin of €104,857 and 2,451 comparable companies of the same size. It probably lies between €170,000 and €400,000. It is a rough estimate.Financials
Is Bio-Perspectives profitable?
In financial year 2025, Bio-Perspectives made a profit of €79,613.
Where can I find the annual accounts of Bio-Perspectives?
Bio-Perspectives filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Bio-Perspectives due?
Bio-Perspectives must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.